[144] Tango Therapeutics, Inc. SEC Filing
Rhea-AI Filing Summary
TNGX submitted a Form 144 notice for proposed sales of Common Stock effective 06/11/2026. The filing lists a $51,523,582.08 figure and multiple lots: 1,791,726 shares (entry), 1,625,739 shares tied to a stock option exercise with a 06/11/2026 date, and 165,987 shares described as restricted stock from 04/01/2017. The excerpt also discloses a reported sale by Daniella Beckman of 4,446 shares on 06/10/2026 for $133,380.00.
The filing names Morgan Stanley Smith Barney LLC as broker and indicates NASDAQ as the market. This Form 144 notifies the SEC and provides holder/sale details; it does not itself execute transfers.
Positive
- None.
Negative
- None.
Insights
Form 144 lists proposed resale quantities and a recent small disposal by an affiliated holder.
The notice identifies multiple share lots including 1,625,739 shares tied to a stock option exercise dated 06/11/2026 and 165,987 shares classified as restricted stock from 04/01/2017. It also shows a sale of 4,446 shares by Daniella Beckman on 06/10/2026 for $133,380.00.
Form 144 is a notice of intent to sell under Rule 144 and does not confirm completion. Subsequent public trade reports or broker confirmations would show whether the proposed resales occurred.